Shanda Asset Management Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-105,400
Closed -$3.27M 91
2020
Q2
$3.27M Sell
105,400
-105,400
-50% -$3.58M 0.3% 52
2020
Q1
$6.53M Buy
+210,800
New +$7.18M 1.51% 17

Other funds holding PFE

Shanda Asset Management Holdings's PFE Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of Pfizer (PFE) in Q3 2020, closing a stake of 105,400 shares — an estimated $3.27M sold.

Shanda Asset Management Holdings first reported a position in PFE in Q1 2020 and held it in 2 quarters. The position peaked at $6.53M in Q1 2020. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 105,400 Pfizer shares in Q3 2020, an estimated $3.27M.
  • Shanda Asset Management Holdings first reported a position in Pfizer in Q1 2020 and held it in 2 quarters.
  • Shanda Asset Management Holdings's Pfizer position peaked at $6.53M in Q1 2020.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.